Closed Loop Medicine

We are excited to announce the appointment of Paul Johnson 🇬🇧🇺🇸 to the Board as an Independent Non-Executive Director. Bringing his unique and extensive experience in developing and scaling digital healthcare and e-commerce platforms, Paul joins at a pivotal stage in the company's development to support the leadership team in advancing the commercialization strategy for our portfolio of integrated precision care solutions. Welcome to our team, Paul! Read more: https://lnkd.in/eviR3G2c #PressRelease #Appointment #PrecisionCare 

This Sunday, our Director of Statistics and Data Science, Thomas Godec PhD, will present the benefits of personalized dosing for the management of hypertension at the European Society of Cardiology (ESC) Congress 2024. “Do more with less? Impact of personalized very low doses of amlodipine in the PERSONAL-CovidBP trial” Session: Hypertension management – drugs 🗓️ 1 September | 🕐 3 PM BST This year’s ESC Congress spotlight is on "Personalizing Cardiovascular Care," focusing on empowering patients through tailored treatments to improve outcomes, reduce risks, and redefine the standard of care. See more details, and register to attend online or in person: https://lnkd.in/evSsFixV Get in touch to arrange a meeting: https://lnkd.in/efQzV5rB #ESCCongress #Hypertension #TechBio #PrecisionCare

Looking forward to being back in #Boston in a few weeks to connect with colleagues old and new, especially in advance of some news to announce about Closed Loop Medicine. Let me know if you are in town 9-11th September - would be great to connect. #PrecisionMedicine

📢 New MedCity News article - Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?   GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound have revolutionized the management of Type 2 diabetes and obesity, but are they living up to the hype? Recent real-world data suggests otherwise.    Despite promising clinical trial results, many patients are discontinuing these therapies in part due to intolerable side effects. This discrepancy between clinical expectations and real-world outcomes raises critical questions: How can we ensure these life-changing drugs are both effective and accessible for all?   Our CEO Hakim Yadi Ph.D. OBE spoke to MedCity News about the urgent need to shift away from a one-size-fits-all approach and the role of digitization and machine learning in overcoming the challenges posed by GLP-1 therapies.    The key to unlocking the full potential of these drugs lies in personalization — tailoring treatment plans to each patient's unique profile, optimizing dosage, minimizing side effects and integrating non-drug solutions.   By integrating advanced digital tools and machine learning, we can deliver personalized care at scale, allowing for precision dosing with minimal physician involvement. This not only maximizes drug efficacy but also enhances patient safety, ultimately leading to better health outcomes.   Read the full article and join the conversation on the future of personalized healthcare ➡ https://lnkd.in/dUTv8Fgj   #PrecisionCare #GLP1 #GLP1SideEffects #DigitalHealthcare #Healthcare

Catch our COO Kate Woolland together with a panel of experts for the final segment of IQVIA UK and Ireland 's “Making Market Access Real” series, focusing on accelerating innovation.   This week’s segment transitions from discussing the challenges behind the implementation of innovative solutions in healthcare to the crucial topic of cross-company adoption of innovation. The panel highlights the importance of bringing together different organizations and focusing on pathways, alongside products, to successfully introduce innovations into the NHS, concluding with top tips for innovators.   At Closed Loop Medicine, our mission is to provide a pathway for all individuals to access high-quality personalized treatment, by enabling real-time, real-world drug dose optimization of both new and established medicines – offering precision care for all whilst supporting healthcare providers and addressing the current shortfall in scalable personalized healthcare solutions.   Listen to the full discussion below 👇   #Healthcare #Innovation #NHS #PrecisionCare

This week, our COO, Kate Woolland, joined IQVIA UK and Ireland , together with a panel of experts, to discuss how to overcome the challenges hindering the adoption of accelerated innovation in the healthcare and life science industry, for the latest installment of "Making Market Access Real".   The main topic of discussion revolved around the unsustainability of healthcare in its current form. Challenges in funding, productivity, workforce shortages, and the backlog in the post-pandemic era, along with health equity and access issues, create significant obstacles. Innovation plays a fundamental part in tackling these challenges. However, it is not the innovation itself but the adoption of innovation that presents the biggest challenge for the industry.   💡 At Closed Loop Medicine, our aim is to provide a pathway for all individuals to access high-quality personalized treatment, addressing the current shortfall in scalable personalized healthcare solutions, by enabling real-time, real-world drug dose optimization of both new and established medicines – offering precision care for all while supporting healthcare providers.   If you haven’t already, watch the video to join the conversation on what’s happening to drive innovation forward. 👇   #Healthcare #Innovation #NHS #PrecisionCare 

📢 New announcement! We have been selected to join NVIDIA Inception, an accelerator program led by world-leading Artificial Intelligence Computing company, NVIDIA, designed to nurture startups and early-stage companies revolutionizing industries with technological advancements. Being able to work closely with NVIDIA’s team and the broader Inception program is a fantastic opportunity, providing the Closed Loop Medicine team with access to the latest tools, expertise, and leading industry and investor networks to accelerate our business growth. The program will support the development of our expanding portfolio of drug-plus-software combination products and entry into broader therapeutic areas. For the full announcement, visit our website: https://lnkd.in/dTarHTsQ #TechBio #NVIDIAInception

This week, our CEO Hakim Yadi Ph.D. OBE will be heading over to Orlando for the American Diabetes Association 84th Annual Scientific Session which begins Friday 21st June. If you're attending the event, reach out to discuss how Closed Loop Medicine is improving outcomes for patients with chronic diseases through its expanding portfolio of drug-plus-software combination products: https://shorturl.at/fMcea   #ADA2024 #TechBio #PrecisionCare

The American Diabetes Association returns for its 84th Annual Scientific Session on June 21st, bringing together researchers, healthcare professionals, and industry experts to delve into the latest advancements in diabetes research, treatment, and care.    With session themes focusing on therapeutics, management of acute or chronic complications, and behavioural medicine, it’s worth highlighting that the effectiveness of any treatment depends on its efficacy, safety, and patient adherence. Patient-centric integrated care approaches that enable real-time patient monitoring play a pivotal role in ensuring medication adherence and mitigating the risk and severity of complications associated with obesity, such as diabetes and hypertension.   Get in touch to arrange a meeting with Hakim Yadi Ph.D. OBE! Learn more about how Closed Loop Medicine is facilitating personalized disease management through our expanding portfolio of drug-plus-software combination products, to improve the effectiveness of medicines, such as GLP-1s, while reducing the impact of adverse effects:  https://shorturl.at/fMcea   #ADA2024 #TechBio #PrecisionCare

Day 2 of the BIO International Convention is in full swing. Irene Patzak,Mel Walker and I are making some great new connections as well as smashing our daily steps targets negotiating the huge conference centre!   Schedule a one-to-one #partnering meeting to learn more about how @Closed Loop Medicine has the potential to transform healthcare and improve patient outcomes through our integrated precision care solutions: https://rb.gy/4dpvcn   #BIO2024 #TechBio #PrecisionCare #DigitalHealth.